PhaseV

PhaseV develops a state-of-the-art AI/ML platform designed to optimize clinical trial design and execution, making it easier for pharmaceutical companies and biotech firms to bring new treatments to market. By leveraging advanced causal inference and real-time data insights, PhaseV empowers sponsors to efficiently navigate the complexities of adaptive clinical trials, resulting in smarter decisions and more successful outcomes.